6/28/2013

CardioFocus has initiated a prospective clinical study of its HeartLight endoscopic ablation device in Europe. The trial, which will involve 150 participants from five clinical sites in the Czech Republic and Germany, will test the device in patients with chronic atrial fibrillation.

Related Summaries